Related references
Note: Only part of the references are listed.Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Martin F. Bachmann et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Induction of myeloid-derived suppressor cells by tumor exosomes
Xiaoyu Xiang et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Nanotechnology in vaccine delivery
Laura J. Peek et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses
Ingrid S. Zeelenberg et al.
CANCER RESEARCH (2008)
Proteomic analysis of microvesicles derived from human colorectal cancer cells
Dong-Sic Choi et al.
JOURNAL OF PROTEOME RESEARCH (2007)
VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases
Farhad Haghighi Rad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Direct stimulation of T cells by membrane vesicles from antigen-presenting cells
Marek Kovar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The regulation of exosome secretion: a novel function of the p53 protein
Xin Yu et al.
CANCER RESEARCH (2006)
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles
ST Reddy et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Liposomal vaccines - targeting the delivery of antigen
Joseph G. Altin et al.
METHODS (2006)
Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells
AE Morelli et al.
BLOOD (2004)
Cancer vaccine development: on the way to break immune tolerance to malignant cells
S Mocellin et al.
EXPERIMENTAL CELL RESEARCH (2004)
Cancer vaccines: Between the idea and the reality
OJ Finn
NATURE REVIEWS IMMUNOLOGY (2003)
Tumor-derived exosomes:: a new source of tumor rejection antigens
F André et al.
VACCINE (2002)
Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction
L Rivoltini et al.
IMMUNOLOGICAL REVIEWS (2002)
Establishment of 15 cancer cell lines from patients with lung cancer and the potential tools for immunotherapy
M Sugaya et al.
CHEST (2002)
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
J Wolfers et al.
NATURE MEDICINE (2001)
Share Paper
